GBA1 and hepatocellular carcinoma: Another study showed that the GBA1 protein, catalyzing the conversion of glucosylceramide (GlcCer) into ganglioside, is downregulated in HCC tissues and stimulates this signaling pathway by mediating GlcCer reprogramming, thus promoting EMT and enhancing the metastatic capability of HCC.